Management of ventilator-associated pneumonia in a multidisciplinary intensive care unit: does trauma make a

Kemal Agbaht1, Thiago Lisboa, Angel Pobo

  • 1CIBER - Enfermedades Respiratorias, University of Rovira & Virgili, Critical Care Department, Joan XXIII University Hospital, Institut Pere Virgili, Carrer Dr. Mallafre Guasch 4, 43007 Tarragona, Spain.

Abstract

Insights

Trauma influences the types of bacteria causing ventilator-associated pneumonia (VAP). Trauma patients had more methicillin-sensitive Staphylococcus aureus (MSSA), while non-trauma patients had more methicillin-resistant Staphylococcus aureus (MRSA).

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Microbiology

Background:

  • Ventilator-associated pneumonia (VAP) is a significant complication in intensive care units.
  • The causative microorganisms in VAP are influenced by factors such as antibiotic exposure and timing of onset.
  • The impact of trauma on VAP microbiology remains less understood.

Purpose of the Study:

  • To investigate the influence of trauma on the prevalence of microorganisms causing VAP.
  • To compare VAP isolates between trauma and non-trauma patient cohorts.
  • To inform antibiotic selection for VAP in trauma patients.

Main Methods:

  • Retrospective, single-center, observational cohort study.
  • Analysis of a 42-month database of adult patients with VAP requiring mechanical ventilation.
  • Comparison of VAP isolates based on the presence or absence of trauma, mechanical ventilation duration, and prior antibiotic exposure.

Main Results:

  • Methicillin-sensitive Staphylococcus aureus (MSSA) was significantly more frequent in trauma patients (34.5%) compared to non-trauma patients (11.5%).
  • Methicillin-resistant Staphylococcus aureus (MRSA) was significantly more frequent in non-trauma patients (11.5%) compared to trauma patients (2%).
  • No significant differences in other microorganisms were observed; MSSA was equally distributed in early- and late-onset VAP in trauma patients, with no early-onset MRSA.

Conclusions:

  • Trauma significantly influences the microbiology of VAP, with a higher prevalence of MSSA in trauma patients.
  • Initial antibiotic regimens for VAP should consider the potential for MSSA in trauma patients.
  • MRSA coverage may be deferred in trauma patients until after 10 days of mechanical ventilation, as no early-onset MRSA was observed in this group.

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Flail Chest-II01:26

Flail Chest-II

Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...